Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial

Flávio Adsuara Cadegiani, Ricardo Ariel Zimerman, Daniel do Nascimento Fonseca, Michael do Nascimento Correia, John McCoy, Carlos Gustavo Wambier, Andy Goren
doi: https://doi.org/10.1101/2021.07.06.21260086

Article usage

Article usage: July 2021 to January 2023

AbstractFullPdf
Jul 2021328927384
Aug 20213532979
Sep 20212738107
Oct 20211851237
Nov 20211721051
Dec 2021126332
Jan 2022111418
Feb 202280012
Mar 202267615
Apr 20221311172
May 20221001340
Jun 2022831934
Jul 2022751232
Aug 202281529
Sep 202278113
Oct 202258021
Nov 202257323
Dec 202267923
Jan 20232509
Back to top
Posted July 10, 2021.
Download PDF
Data/Code
Email
Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
Flávio Adsuara Cadegiani, Ricardo Ariel Zimerman, Daniel do Nascimento Fonseca, Michael do Nascimento Correia, John McCoy, Carlos Gustavo Wambier, Andy Goren
medRxiv 2021.07.06.21260086; doi: https://doi.org/10.1101/2021.07.06.21260086
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area